Evolent Health(EVH) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Average PMPM Fees/ Revenue per Case Evolent Announces Second Quarter 2024 Results • Revenue of $647.1 million, an increase of$178.0 million or 37.9%, from the three months ended June 30, 2023. • Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and a net loss margin of (1.0)$52.0 million resulting in an Adjusted EBITDA margin of 8.0%. • Narrows revenue outlook for full year 2024 and provides updated 2024 Adjusted EBITDA guidance. • R ...